These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9597554)
1. Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects. Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI J Clin Pharmacol; 1998 Jan; 38(1):14-21. PubMed ID: 9597554 [TBL] [Abstract][Full Text] [Related]
2. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam. Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI J Clin Psychopharmacol; 2000 Jun; 20(3):338-46. PubMed ID: 10831021 [TBL] [Abstract][Full Text] [Related]
3. Kinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteers. Venkatakrishnan K; Culm KE; Ehrenberg BL; Harmatz JS; Corbett KE; Fleishaker JC; Greenblatt DJ J Clin Pharmacol; 2005 May; 45(5):529-37. PubMed ID: 15831776 [TBL] [Abstract][Full Text] [Related]
4. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences. Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147 [TBL] [Abstract][Full Text] [Related]
5. Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam. Yasui N; Kondo T; Otani K; Furukori H; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K Psychopharmacology (Berl); 1998 Oct; 139(3):269-73. PubMed ID: 9784084 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state. Scavone JM; Greenblatt DJ; Goddard JE; Friedman H; Harmatz JS; Shader RI Eur J Clin Pharmacol; 1992; 42(4):439-43. PubMed ID: 1516609 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry. Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and psychomotor performance of alprazolam: concentration-effect relationship. Wright CE; Sisson TL; Fleishaker JC; Antal EJ J Clin Pharmacol; 1997 Apr; 37(4):321-9. PubMed ID: 9115058 [TBL] [Abstract][Full Text] [Related]
9. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism. Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822 [TBL] [Abstract][Full Text] [Related]
10. Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam. Furukori H; Otani K; Yasui N; Kondo T; Kaneko S; Shimoyama R; Ohkubo T; Nagasaki T; Sugawara K Neuropsychopharmacology; 1998 May; 18(5):364-9. PubMed ID: 9536449 [TBL] [Abstract][Full Text] [Related]
11. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment. Kroboth PD; Folan MM; Lush RM; Chaikin PC; Shukla UA; Barbhaiya R; Salazar DE J Clin Psychopharmacol; 1995 Oct; 15(5):306-19. PubMed ID: 8830061 [TBL] [Abstract][Full Text] [Related]
12. Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo. Greenblatt DJ; Harmatz JS; Dorsey C; Shader RI Clin Pharmacol Ther; 1988 Sep; 44(3):326-34. PubMed ID: 3138056 [TBL] [Abstract][Full Text] [Related]
13. Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects. Bertz RJ; Kroboth PD; Kroboth FJ; Reynolds IJ; Salek F; Wright CE; Smith RB J Pharmacol Exp Ther; 1997 Jun; 281(3):1317-29. PubMed ID: 9190868 [TBL] [Abstract][Full Text] [Related]
14. Effect of venlafaxine on the pharmacokinetics of alprazolam. Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM Psychopharmacol Bull; 1998; 34(2):211-9. PubMed ID: 9641003 [TBL] [Abstract][Full Text] [Related]
15. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam. Busto UE; Kaplan HL; Wright CE; Gomez-Mancilla B; Zawertailo L; Greenblatt DJ; Sellers EM J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134 [TBL] [Abstract][Full Text] [Related]
16. [The relationship between single-oral dose kinetics of alprazolam and cytochrome P4503A and cytochrome P4502C19]. Yasui N Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):109-12. PubMed ID: 8905799 [TBL] [Abstract][Full Text] [Related]
17. Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing. Kroboth PD; McAuley JW; Smith RB Psychopharmacology (Berl); 1990; 100(4):477-84. PubMed ID: 2320708 [TBL] [Abstract][Full Text] [Related]
19. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects. Park JY; Kim KA; Park PW; Lee OJ; Kang DK; Shon JH; Liu KH; Shin JG Clin Pharmacol Ther; 2006 Jun; 79(6):590-9. PubMed ID: 16765147 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam. DeVane CL; Ware MR; Lydiard RB Psychopharmacol Bull; 1991; 27(4):463-73. PubMed ID: 1687613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]